Rhinocort

Rhinocort Overview

Status Acquired/​Merged
Latest Deal Type Asset Purch.
Financing Rounds 1

Rhinocort General Information

Description

Rights to Rhinocort Aqua. The asset is a nasal spray indicated for allergic and non-allergic rhinitis, inflammation of the inside of the nose and for the treatment of nasal polyps like swelling of the nasal lining.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Acquirer
Janssen-Cilag
Primary Office
  • Cambridge
  • England, United Kingdom
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Rhinocort Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Rhinocort‘s full profile, request access.

Request a free trial

Rhinocort Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Rhinocort‘s full profile, request access.

Request a free trial